A detailed history of Cwm, LLC transactions in Viridian Therapeutics, Inc.\De stock. As of the latest transaction made, Cwm, LLC holds 128 shares of VRDN stock, worth $2,470. This represents 0.0% of its overall portfolio holdings.

Number of Shares
128
Previous 117 9.4%
Holding current value
$2,470
Previous $3,000 33.33%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 04, 2025

BUY
$17.85 - $25.71 $196 - $282
11 Added 9.4%
128 $2,000
Q3 2024

Oct 08, 2024

BUY
$12.16 - $23.33 $304 - $583
25 Added 27.17%
117 $3,000
Q2 2024

Jul 09, 2024

BUY
$11.6 - $17.26 $1,067 - $1,587
92 New
92 $1,000
Q3 2023

Oct 11, 2023

BUY
$15.16 - $24.7 $212 - $345
14 New
14 $0

Others Institutions Holding VRDN

About Viridian Therapeutics, Inc.\DE


  • Ticker VRDN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,888,900
  • Market Cap $770M
  • Description
  • Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients suffering from serious diseases. It develops VRDN-001, a humanized monoclonal anti-IGF-1R antibody that is in Phase 1/2 clinical trial for the treatment of thyroid eye disease (TED); VRDN-002, an IGF-1R antibody, which is in Phase 1 clinical trial; and VRDN-00...
More about VRDN
Track This Portfolio

Track Cwm, LLC Portfolio

Follow Cwm, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.